Form D · Pharmaceuticals

EIKONOKLASTES THERAPEUTICS, INC.

Cincinnati, OH · CIK 0001805698

Offering snapshot reported Jul 29, 2025 · SEC filing

Reported sold
$13.6M
Offering amount: $15.8M
Investors reported
14
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 14, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 29, 2025Initial$13,555,109No comparison14SEC filing
Jun 25, 2024Initial$2,400,000No comparison3SEC filing
Nov 27, 2023Initial$2,000,000No comparison1SEC filing
Jan 13, 2022Initial$2,800,000No comparison1SEC filing
May 6, 2021Initial$3,176,754No comparison9SEC filing
Mar 5, 2020Initial$1,100,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-552987

Source: Form D, filed Jul 29, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thomas Finn Director
Meyer Frucher Director
Bruce Halpryn Director, Executive
Robert Johnson Director
Samuel Lee Director, Executive
Kenneth Morand Director
Joseph Nolan Director
Neel Patel Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
2356 Park Avenue Unit 17
Cincinnati, OH, 45206
Phone: (513) 549-6484